Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma

NCT06781073 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Cervical Squamous Cell Carcinoma
Persistent

Interventions

DRUG: Nimotuzumab
DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Placebo

Sponsor

Biotech Pharmaceutical Co., Ltd.